Midatech Pharma US Inc. 4
4 · Midatech Pharma US Inc. · Filed Dec 7, 2015
Insider Transaction Report
Form 4
Tousley David L.
Acting Chief Financial Officer
Transactions
- Disposition to Issuer
Stock Option
2015-12-04−35,000→ 0 totalExercise: $0.69From: 2019-05-19Exp: 2025-05-19→ Common Stock (35,000 underlying) - Disposition to Issuer
Stock Option
2015-12-04−35,000→ 0 totalExercise: $4.90From: 2015-12-04Exp: 2023-03-01→ Common Stock (35,000 underlying) - Disposition to Issuer
Stock Option
2015-12-04−40,000→ 0 totalExercise: $2.90From: 2015-12-04Exp: 2024-03-04→ Common Stock (40,000 underlying) - Disposition to Issuer
Stock Option
2015-12-04−97,000→ 0 totalExercise: $0.79From: 2015-12-04Exp: 2025-02-09→ Common Stock (97,000 underlying)
Footnotes (1)
- [F1]In connection with the closing of the Agreement and Plan of Merger among DARA BioSciences, Inc. (DARA), Midatech Pharma PLC (Midatech) and certain other parties thereto, these options were assumed by Midatech and replaced with options to purchase 0.136 Midatech American Depository Receipts (Midatech ADRs) for each DARA option held, at an exercise price equal to the exercise price of the applicable DARA option divided by 0.136. Each Midatech ADR represents two Midatech ordinary shares.